| http://www.w3.org/ns/prov#value | - In the meantime, bevacizumab has been used off-label in thousands of patients with AMD. According to the manufacturer, however, there are a number of differences between bevacizumab and ranibizumab (Bandolier, 2007): (i) bevacizumab contains no preservatives, so there could be problems in keeping it sterile when split into small quantities required for retinal treatment; (ii) no preclinical trial
|
